DESIGN AND IN VIVO EVALUATION OF NAPROXEN-LOADED TRANSFEROSOMAL GEL FOR TRANSDERMAL DELIVERY

HIMA BINDU E.; RADHA G. V.

doi:10.22159/ijap.2024v16i2.49562

Authors

HIMA BINDU E. Department of Pharmaceutics, GITAM School of Pharmacy, GITAM Deemed to be University, Visakhapatnam-530045, Andhra Pradesh, India https://orcid.org/0009-0007-2580-2789
RADHA G. V. Department of Pharmaceutics, GITAM School of Pharmacy, GITAM Deemed to be University, Visakhapatnam-530045, Andhra Pradesh, India https://orcid.org/0000-0001-6726-2185

DOI:

https://doi.org/10.22159/ijap.2024v16i2.49562

Keywords:

Naproxen, Transfersomal gel, Reverse phase evaporation, Central composite design, Independent process variables, Dependent variables

Abstract

Objective: The main objective of the present study was to formulate, optimize, and evaluate naproxen transfersomal gels.

Methods: Reverse phase evaporation was used to create thirteen different formulations of naproxen-loaded transfersomes. Using Response Surface Methodology (RSM) and Central Composite Designs (CCD), the influence of independent process variables, such as soy lecithin, cholesterol content and surfactant concentration, on dependent variables, such as entrapment effectiveness and vesicle size of naproxen transfersomes, was assessed. In vitro, ex-vivo, and in vivo drug release of formulations were also studied.

Results: It was discovered that the NTG7 formulation of transfersomes had the maximum entrapment effectiveness and ideal vesicle diameter. The optimized NTG7 formulation displayed a maximum drug content of 97.4% and a maximum drug release of 88.03%. The release of naproxen from the final gel adhered to the Korsmeyer-Peppas release model. The ex-vivo drug release of the optimized formulation was found to be 85.91% for 24 h. The maximum drug concentration after oral administration was 843.54±7.67ng/ml, and T_max was 3.0±0.08h. The improved formulation's AUC_0-∞was greater than the commercial formulation's. A higher drug concentration in the blood compared to the marketed formulation suggested better systemic absorption of naproxen from the gel formulation. After three months, at a temperature range of 2 to 8 °C, the formulation demonstrated correct semisolid consistency and good stability and there was also no appreciable change in the initial values of appearance, pH, and % drug content.

Conclusion: The above findings imply that the gel created using naproxen-loaded transfersomes may be a potentially valuable new formulation.

Downloads

Download data is not yet available.

References

Benson HA. Transfersomes for transdermal drug delivery. Expert Opin Drug Deliv. 2006;3(6):727-37. doi: 10.1517/17425247.3.6.727, PMID 17076595.

Rangasamy M, Kugalur GP, Sanaullah S, Balasubramaniam S, Natesan SK. Formulation development and evaluation of naproxen sodium tablets USP. Int J Drug Dev Res. 2010;2(1):47-53.

Suryam G, Prasanna KD. Formulation and evaluation of naproxen proliposomal gels. World J Pharm Pharm Sci. 2019;8(11):331-40.

Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther. 1994;268(1):144-51. PMID 8301551.

Goosen C, du Plessis J, Müller DG, Janse van Rensburg LF. Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID’s. International Journal of Pharmaceutics. 1998;163(1-2):203-9. doi: 10.1016/S0378-5173(97)00359-1.

Snehal AT, Nagesh HA, Nilesh SD, Riyaz MO, Birudev BK, Yogita RI. Formulation and evaluation of novel gel containing liquid crystals of naproxen. Am J Adv Drug Deliv. 2014;2(3):364-86.

Gupta V, Dwivedi A, Trivedi N, Jain NK, Garud N, Jain DK. Formulation and evaluation of naproxen gel containing Tulsi oil as a penetration enhancer. Int J Pharm Clin Res. 2009;1(3):153-5.

Pastore MN, Kalia YN, Horstmann M, Roberts MS. Transdermal patches: history, development and pharmacology. Br J Pharmacol. 2015;172(9):2179-209. doi: 10.1111/bph.13059, PMID 25560046.

Isaac M, Holvey C. Transdermal patches: the emerging mode of drug delivery system in psychiatry. Ther Adv Psychopharmacol. 2012;2(6):255-63. doi: 10.1177/2045125312458311, PMID 23983984.

Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Ther Deliv. 2010;1(1):109-31. doi: 10.4155/tde.10.16, PMID 21132122.

Marwa HA, Amr SAL, Seham MS, Khaled A, Farhan A, El-Sayed K. Experimental design and optimization of nano-transpersonal gel to enhance the hypoglycemic activity of silymarin. Poly. 2022;14:508.

Silvia S, Puteri DN, Adelia RP, Kurnia SSP. Formulation of andrographolide transfersomes gel for transdermal delivery: a preliminary study. Int J Appl Pharm. 2020;12(1):187-91.

Jessy S, Maria L. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a cox-2 inhibitor. Int J Pharm Pharm Sci. 2014;6(1):467-77.

Rakesh P, Shweta P, Kamal S, Parul W, Manish K. Transferosomes: unique vesicular carriers for effective transdermal delivery. J Appl Pharm Sci. 2021;11(05):1-8. doi: 10.7324/JAPS.2021.110501.

Qindeel M, Ullah MH, Fakhar-ud-Din UD, Ahmed N, Rehman UR. Recent trends, challenges and future outlook of transdermal drug delivery systems for rheumatoid arthritis therapy. J Control Rel. 2020;327:595-615. doi: 10.1016/j.jconrel.2020.09.016.

Shakthi A, Thejani O, VarinTi RC. Transfersomes: a promising nanoencapsulation technique for transdermal drug delivery. Pharm. 2020;12:855.

Prabhjot K, Varun G, Palak B, Roopesh S, Sachin KS, Bimlesh K. Formulation, systematic optimization, in vitro, ex vivo, and stability assessment of transethosome based gel of curcumin. Asian J Pharm Clin Res. 2018;11(2):41-7.

Malakar J, Sen SO, Nayak AK, Sen KK. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm J. 2012;20(4):355-63. doi: 10.1016/j.jsps.2012.02.001, PMID 23960810.

Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 2004;270(1-2):119-25. doi: 10.1016/j.ijpharm.2003.10.006, PMID 14726128.

Nasr M, Abdel Hamid S. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev Ind Pharm. 2016;42(4):636-43. doi: 10.3109/03639045.2015.1062512, PMID 26133080.

Biswarup D, Suma OS, Ruma M, Amit KN, Kalyan KS. Transferosomal gel for transdermal delivery of risperidone: formulation optimization and ex vivo permeation. J Drug Deliv Sci Technol. 2017;38.

Jangdey MS, Gupta A, Saraf S, Saraf S. Development and optimization of apigenin-loaded transfersomal system for skin cancer delivery: in vitro evaluation. Artif Cells Nanomed Biotechnol. 2017;45(7):1452-62. doi: 10.1080/21691401.2016.1247850, PMID 28050929.

Bhatia N, Katkar K, Ashtekar S. Formulation and evaluation of co-prodrug of flurbiprofen and methocarbamol. Asian J Pharm Sci. 2016;11(3):449-58. doi: 10.1016/j.ajps.2015.10.031.

Mangalathillam S, Rejinold NS, Nair A, Lakshmanan VK, Nair SV, Jayakumar R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale. 2012;4(1):239-50. doi: 10.1039/c1nr11271f, PMID 22080352.

Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro, in vivo characterization. Drug Dev Ind Pharm. 2016;42(7):1032-41. doi: 10.3109/03639045.2015.1107089, PMID 26559059.

Saraf S, Jeswani G, Kaur CD, Saraf S. Development of novel herbal cosmetic cream with curcuma longa extract loaded transfersomes for anti-wrinkle effect. Afr J Pharm Pharmacol. 2011;5:1054-62.

Ali MS, Alam MS, Alam N, Alam MI, Imam F, Ali MD. Formulation, characterization, and in vivo study of nanoemulsion topical gel of beclomethasone propionate for psoriasis. World J Pharm Pharm Sci. 2012;1:839-57.

Gajra B, Patel RR, Dalwadi C. Formulation, optimization and characterization of cationic polymeric nanoparticles of mast cell stabilizing agent using the box-Behnken experimental design. Drug Dev Ind Pharm. 2016;42(5):747-57. doi: 10.3109/03639045.2015.1093496, PMID 26559522.

Khan MA, Pandit J, Sultana Y, Sultana S, Ali A, Aqil M. Novel carbopol-based transfersomal gel of 5-fluorouracil for skin cancer treatment: in vitro characterization and in vivo study. Drug Deliv. 2015;22(6):795-802. doi: 10.3109/10717544.2014.902146, PMID 24735246.

Palem CR, Dudhipala NR, Battu SK, Repka MA, Rao Yamsani MR. Development, optimization and in vivo characterization of domperidone-controlled release hot-melt-extruded films for buccal delivery. Drug Dev Ind Pharm. 2016;42(3):473-84. doi: 10.3109/03639045.2015.1104346, PMID 26530127.

Alexander A, Saraf S, Saraf S. A comparative study of chitosan and poloxamer based thermosensitive hydrogel for the delivery of PEGylated melphalan conjugates. Drug Dev Ind Pharm. 2015;41(12):1954-61. doi: 10.3109/03639045.2015.1011167, PMID 25678314.

Gupta A, Kaur CD, Saraf S, Saraf S. Formulation, characterization, and evaluation of ligand-conjugated biodegradable quercetin nanoparticles for active targeting. Artif Cells Nanomed Biotechnol. 2016;44(3):960-70. doi: 10.3109/21691401.2015.1008503, PMID 25813566.

Jain SK, Jangdey MS. Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori. Mol Pharm. 2009;6(1):295-304. doi: 10.1021/mp800193n, PMID 19093870.

Sarwa KK, Das PJ, Mazumder B. A nanovesicle topical formulation of Bhut Jolokia (hottest capsicum): a potential anti-arthritic medicine. Expert Opin Drug Deliv. 2014;11(5):661-76. doi: 10.1517/17425247.2014.891581, PMID 24661126.

Hussain G, Kohli K, Umar A, Amin S. Nanovesicular delivery of repaglinide through skin. Sci Adv Mater. 2013;5(7):810-21. doi: 10.1166/sam.2013.1522.

Kumar S, Debnath M, Rao J, Sankar D. A new bioanalytical method development and validation for simultaneous estimation of esomeprazole and naproxen in human plasma by using RP-HPLC. Br J Pharm Res. 2014;4(19):2312-27. doi: 10.9734/BJPR/2014/10918.

Ramkanth S, Chetty CM, Sudhakar Y, Thiruvengadarajan VS, Anitha P, Gopinath C. Development, characterization & in vivo evaluation of proniosomal based transdermal delivery system of Atenolol. Future J Pharm Sci. 2018;4(1):80-7. doi: 10.1016/j.fjps.2017.10.003.

Syed SI. Topical formulation constituted with transferosomes for the treatment of non-melanoma skin cancer. Asian J Pharm Clin Res. 2023;16(5):27-32.

Magdy IM, Amna MAM, Menna MA. Formulation and characterization of ethosomes bearing vancomycin hydrochloride for transdermal delivery. Int J Pharm Pharm Sci. 2014;6(11):190-4.

Shayma K, Naina D, Basant K, Harshita J, Prateek Kumar J. Preparation and characterization of alginate chitosan crosslinked nanoparticles bearing drug for the effective management of ulcerative colitis. Int J Curr Pharm Res. 2022;14(5):48-61.

Meng S, Chen Z, Yang L, Zhang W, Liu D, Guo J. Enhanced transdermal bioavailability of testosterone propionate via surfactant-modified ethosomes. Int J Nanomedicine. 2013;8:3051-60. doi: 10.2147/IJN.S46748, PMID 23990718.